Adderall shortage due to Teva Pharma manufacturing delays
FDA confirms Adderall shortage due to problems in Teva Pharma's supply pipeline
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
FDA confirms Adderall shortage due to problems in Teva Pharma's supply pipeline
Moderna’s mRNA vaccine is being studied in combination with Merck’s Keytruda to treat patients with high-risk melanoma
Neumora Therapeutics raises $650 million to date to revolutionize treatment of brain diseases
Evgen Pharma and Stalicla sign a $165 million licensing deal for neuro development disorder SFX-01 asset
Merck's Covid-19 pill no help in reducing hospitalization or death, Astrazenaca's nasal spray too fails trial
New malaria vaccine by Oxford University has 80% efficacy
The EC has intimated Teva Pharmaceutical Industries, an Israel-based global company, of its "preliminary view" that it has breached EU antitrust rules by.
Japanese scientists develop method to detect alzheimer's in blood by measuring amyloid β build up.
A new study reveals cellular changes that take place in response to exercise and high-fat diets
New gene responsible for malfunctioning of lysosome pathways discovered by Michigan researchers